<i>De novo</i> serine biosynthesis is protective in mitochondrial disease
Christopher B. Jackson(Memorial Sloan Kettering Cancer Center), Anu Suomalainen(University of Helsinki), Thomas Langer(University of Cologne), Christopher J. Carroll(St George's, University of London), Anastasiia Marmyleva(University of Helsinki), Amy E. Vincent(Muscular Dystrophy UK), Geoffray Monteuuis(University of Helsinki), Takayuki Mito(University of Helsinki), Takashi Tatsuta(Max Planck Institute for Biology of Ageing), Ryan Awadhpersad(University of Helsinki), Nicola Zamboni(Scuola Internazionale Superiore di Studi Avanzati), Liya Wang(Swedish University of Agricultural Sciences)
Cited by 2
Related Papers
Mitochondrial diseases
|Nature Reviews Disease Primers|2016|1.5k
A roadmap for interpreting 13C metabolite labeling patterns from cells
|Current Opinion in Biotechnology|2015|652
Making heads or tails of phospholipids in mitochondria
|The Journal of Cell Biology|2011|580
Mitochondrial quality control: a matter of life and death for neurons
|The EMBO Journal|2012|424
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420